Platelet count predicts driver mutations' co-occurrence in low JAK2 mutated essential thrombocythemia and myelofibrosis

Autor: Daniela Barraco, Matteo G. Della Porta, Raffaella Accetta, Daniela Pietra, Marta Ubezio, Francesco Pallotti, Barbara Mora, Margherita Maffioli, Laura Libera, Rosario Casalone, Francesco Passamonti, Michele Merli, Chiara Trotti, Ilaria Carola Casetti, Luca Arcaini, Silvia Uccella, Marianna Rossi, Lorenza Bertù, Claudia Siracusa, Elisa Rumi

Publikováno v: Leukemia. 35(5)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d72e4691bcef95307df71db6eb91dd41
https://pubmed.ncbi.nlm.nih.gov/33051550

Analysis of three screening methods for the detection of calreticulin gene mutations

Autor: Francesca Cassavia, Linda Orlandi, Lorenzo Elli, Francesco Pallotti, Raffaella Accetta, Rosario Casalone, Claudia Siracusa, Laura Libera, Francesco Passamonti, Francesco Orsini

Publikováno v: International Journal of Laboratory Hematology. 42

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9924f30157917bf4ab01d133ef94a08b
https://doi.org/10.1111/ijlh.13117

Second primary malignancies in ruxolitinib-treated myelofibrosis: Real-world evidence from 219 consecutive patients

Autor: Elena Maria Elli, Toni Giorgino, Lorenza Bertù, Elisa Rumi, Chiara Cavalloni, Marianna Caramella, Alessandro Vismara, Daniela Barraco, Margherita Maffioli, Maria Chiara Finazzi, Mariella D'Adda, Francesco Spina, Daniele Cattaneo, Francesco Passamonti, Nicola Polverelli, Simona Malato, Maria Cristina Carraro, Alfredo Molteni, Barbara Mora, Alessandra Iurlo, Maria Luisa Pioltelli, Marianna Rossi, Rossella Renso, Raffaella Accetta, Matteo G. Della Porta, Michela Anghilieri, Marta Bellini, Cinzia Sissa

Publikováno v: Blood advances 3 (2019): 3196–3200. doi:10.1182/bloodadvances.2019000646
info:cnr-pdr/source/autori:Margherita Maffioli and Toni Giorgino and Barbara Mora and Alessandra Iurlo and Elena Elli and Maria Chiara Finazzi and Marianna Caramella and Elisa Rumi and Maria Cristina Carraro and Nicola Polverelli and Mariella D'Adda and Simona Malato and Marianna Rossi and Alfredo Molteni and Alessandro Vismara and Cinzia Sissa and Francesco Spina and Michela Anghilieri and Daniele Cattaneo and Rossella Renso and Marta Bellini and Maria Luisa Pioltelli and Chiara Cavalloni and Daniela Barraco and Raffaella Accetta and Lorenza Bert`u and Matteo Giovanni Della Porta and Francesco Passamonti/titolo:Second primary malignancies in ruxolitinib-treated myelofibrosis: real-world evidence from 219 consecutive patients/doi:10.1182%2Fbloodadvances.2019000646/rivista:Blood advances/anno:2019/pagina_da:3196/pagina_a:3200/intervallo_pagine:3196–3200/volume:3

Myeloproliferative neoplasms (MPNs) are clonal disorders that include polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). Patients with MPNs have a higher risk than the general population of developing a lymphoid

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89a5b41a649ae26b37c0e831ce0956bf
https://hdl.handle.net/11379/569789